期刊文献+

Therapeutic effect and apoptosis mechanism of lung-tonifying and expectorant decoction on lung cancer rats with Qi deficiency and blood stasis 被引量:5

Therapeutic effect and apoptosis mechanism of lung-tonifying and expectorant decoction on lung cancer rats with Qi deficiency and blood stasis
下载PDF
导出
摘要 Objective:To explore the effect and specific mechanism of lung-tonifying and expectorant decoction on lung cancer rats with Qi deficiency and blood stasis,and aim to provide a new idea on treating the disease with traditional Chinese medicine based on syndrome differentiation.Methods:A total of 60 C57BL/6J male rats were included in the study.The model of Qi deficiency and blood stasis was established in 60 rats by using multiple-factor stimulation.About 10 rats were randomly taken to verify whether the model establishment was successful and the rest of 50 rats were divided into 5 groups with 10 rats each:blank control group,cisplatin group,low dose group,medium dose group and high dose group.The blank control group was treated with normal saline,and cisplatin group was treated with cisplatin while the other three groups were treated with lung-tonifying and expectorant decoction at different doses.The volume change in transplanted tumor,tumor inhibition rate,apoptosis rate,and expression of Bc1-2,Bax.cleaved caspase-3 and cleaved caspase-9 in 5 groups were compared.Results:The rapidest growth rate of transplanted tumor volume was observed in blank control group and the slowest in cisplatin group.The growth rate was gradually decreased with the increasing dose of lung-tonifying and expectorant decoction,and the difference in growth of tumor volume among groups was statistically significant(P<0.05).The cisplatin group showed the highest tumor inhibition rate,with dose-dependent increase(P<0.05).The apoptosis rate in low dose group was higher than blank control group but lower than high dose group(P<0.05).The apoptosis rate in medium dose group was significantly higher man blank control group(P).05).The apoptosis rate in high dose group was significantly higher than control group(P<0.05).The positive expression rates of Bel-2 and Bax in all groups showed statistically significant difference(P<0.05),while expression of cleaved caspase-3 and cleaved caspase-9 in 5 groups was significantly different,with dose-dependent increase(P<0.05).Conclusions:The lung-tonifying and expectorant decoction inhibits the proliferation of tumor cells by inducing and activating the cell apoptosis in treatment of lung cancer with Qi deficiency and blood stasis,probably with good clinical therapeutic effect. Objective:To explore the effect and specific mechanism of lung-tonifying and expectorant decoction on lung cancer rats with Qi deficiency and blood stasis,and aim to provide a new idea on treating the disease with traditional Chinese medicine based on syndrome differentiation.Methods:A total of 60 C57BL/6J male rats were included in the study.The model of Qi deficiency and blood stasis was established in 60 rats by using multiple-factor stimulation.About 10 rats were randomly taken to verify whether the model establishment was successful and the rest of 50 rats were divided into 5 groups with 10 rats each:blank control group,cisplatin group,low dose group,medium dose group and high dose group.The blank control group was treated with normal saline,and cisplatin group was treated with cisplatin while the other three groups were treated with lung-tonifying and expectorant decoction at different doses.The volume change in transplanted tumor,tumor inhibition rate,apoptosis rate,and expression of Bc1-2,Bax.cleaved caspase-3 and cleaved caspase-9 in 5 groups were compared.Results:The rapidest growth rate of transplanted tumor volume was observed in blank control group and the slowest in cisplatin group.The growth rate was gradually decreased with the increasing dose of lung-tonifying and expectorant decoction,and the difference in growth of tumor volume among groups was statistically significant(P<0.05).The cisplatin group showed the highest tumor inhibition rate,with dose-dependent increase(P<0.05).The apoptosis rate in low dose group was higher than blank control group but lower than high dose group(P<0.05).The apoptosis rate in medium dose group was significantly higher man blank control group(P).05).The apoptosis rate in high dose group was significantly higher than control group(P<0.05).The positive expression rates of Bel-2 and Bax in all groups showed statistically significant difference(P<0.05),while expression of cleaved caspase-3 and cleaved caspase-9 in 5 groups was significantly different,with dose-dependent increase(P<0.05).Conclusions:The lung-tonifying and expectorant decoction inhibits the proliferation of tumor cells by inducing and activating the cell apoptosis in treatment of lung cancer with Qi deficiency and blood stasis,probably with good clinical therapeutic effect.
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2015年第11期957-962,共6页 亚太热带医药杂志(英文版)
基金 supported by Guangxi Nature Fund.2015
关键词 Lung cancer Qi DEFICIENCY and blood STASIS Lung-to Lung cancer Qi deficiency and blood stasis Lung-to
  • 相关文献

参考文献1

二级参考文献22

  • 1Shimizu M,Saitoh Y,Itoh H.Immunohistochemical staining of Haras oncogene product in normal,benign,and malignant?human pancreatic tissues[J].Hum Pathol,1990,21:607-612.
  • 2Weidner N,Sem Ple JP,Welch WR,et al.Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma[J].New Engl J Med,1991,324:1-8.
  • 3Toi M,Kondo S,Suzuki H et al.Qauntitative analysis of vascular endothelial growth factor in Primary breast cancer[J].Cancer,1996,77(6):1101-6.
  • 4Takigawa N,Segawa Y,Fujimoto N et al.Elevated vascular endothelial growth factor levels in sera of Patients with lung cancer[J].Anticancer Res,1998,18(28):1251-4.
  • 5Banai S,Jaklisch MT,Shon M.Angiogenic-indued enhancement of collteral blcod flow to ischemia myocardium by vascular endothelial growth factor I dogs[J].Circulation,1994,89:2183-2189.
  • 6Mc Donnell CO,Hill ADK,Mc Namara DA,et al.Tumor microetastases:The influence of angiogenesis[J].Euro J Surg On col,2000,26(2):105-115.
  • 7Dannenberg A J,Altorki N K,Boyle JO,et al.Cyclooxygenase K2:A pharmacologic target for the prevention of cancer[J].Lancet Oncol,2001,2(9):544-551.
  • 8Reddy BS,Rao CV,Seibert K.Evaluation of cyclooxygenase-2inhibitor for potential chemopreventive properties in colon carcinogenesis[J].Cancer Res,1996,56(3):4566-4569.
  • 9Sweeney CJ.Why cycooxygenase-2 inhibitor plus chemotherapy[J].Am J Clin Oncol(CCT),2003,26(4):sl22-sl25.
  • 10Meert AP,Martin B,Delmotte P,et al,The role of EGF-R expression on patient survival in lung cancer,a systematic review with meta-analysis[J].Eur Respir J,2002,20(4):975-998.

共引文献14

同被引文献51

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部